Exaggerated sympathetic mediated responses to behavioral or pharmacological challenges following antenatal betamethasone exposure.
about
HORSE SPECIES SYMPOSIUM: Glucocorticoid programming of hypothalamic-pituitary-adrenal axis and metabolic function: Animal studies from mouse to horseAngiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressure.Enhanced activity of an angiotensin-(1-7) neuropeptidase in glucocorticoid-induced fetal programmingIn vivo expression of angiotensin-(1-7) lowers blood pressure and improves baroreflex function in transgenic (mRen2)27 ratsFetal betamethasone exposure attenuates angiotensin-(1-7)-Mas receptor expression in the dorsal medulla of adult sheep.Autonomic and Renal Alterations in the Offspring of Sleep-Restricted Mothers During Late PregnancyAntenatal betamethasone exposure is associated with lower ANG-(1-7) and increased ACE in the CSF of adult sheepEpigenetics and developmental programming of adult onset diseases.Short- and long-term effects of exposure to natural and synthetic glucocorticoids during development.Early life obesity and chronic kidney disease in later life.Antenatal glucocorticoids: where are we after forty years?Fetal and Neonatal HPA Axis.In Utero Origins of Hypertension: Mechanisms and Targets for Therapy.Altered autonomic control in preterm newborns with impaired neurological outcomes.Excess prenatal corticosterone exposure results in albuminuria, sex-specific hypotension, and altered heart rate responses to restraint stress in aged adult mice.
P2860
Q26781816-A852229C-FB08-4CEB-B3DA-C09D6B6B38B2Q34147493-40983D3A-DA7B-459E-82A3-83BF1F75C025Q34147653-480409BF-3DE7-435F-98A9-F02163DDE963Q36166258-8C422D97-B4A0-4E7E-A8F7-6420DA02CFB5Q36949167-B6D64D27-1578-410D-9789-C935C6653972Q37216694-95E4FDAA-63F2-4873-84C0-6E9246A016C3Q37235018-BF048E9B-BF3B-4648-AF9F-3C6992A60930Q37981128-A3DBE9E5-CC69-47A4-8FDF-B9482BEDCB50Q38042716-3A3140B4-81FB-4126-A68A-CBB1C8C1E988Q38241975-7D49BDA6-C0A8-4880-946F-226348C44E2FQ38281536-649C23C2-F406-4DF5-B303-E49728C5F467Q38693264-5FB98152-DF77-45CB-AB7B-71851B6C5643Q38737743-00BBCF8B-023A-49A0-96D1-F1217F59BED7Q41503112-045BEBC1-9E49-4DF0-8F85-49FE7495C0ADQ50599013-E9476A3A-5A21-43C4-82C4-1DDDB3051AFA
P2860
Exaggerated sympathetic mediated responses to behavioral or pharmacological challenges following antenatal betamethasone exposure.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@ast
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@en
type
label
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@ast
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@en
prefLabel
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@ast
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@en
P2860
P1476
Exaggerated sympathetic mediat ...... enatal betamethasone exposure.
@en
P2093
James C Rose
Mark C Chappell
P2860
P304
P356
10.1152/AJPENDO.00636.2010
P577
2011-03-08T00:00:00Z